Status:
COMPLETED
Impact of Oral Hygiene Instructions in the Resolution of Peri-implant Mucositis
Lead Sponsor:
Universitat Internacional de Catalunya
Conditions:
Peri-implant Mucositis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peri-implant mucositis (PM) over dental implants is a highly prevalent disease characterized by inflammation of the peri-implant mucosa without loss of supporting bone around implants. If untreated, P...
Eligibility Criteria
Inclusion
- Presence of, at least, one titanium implant that have been more than one year in function and exhibits PM, defined as bleeding on gentle probing (0.20 N) in at least one peri-implant site.
- No signs of loss of supporting bone after initial bone remodelling. In cases where baseline radiograph is available, it will be used for comparison, otherwise a maximum of 2 mm of crestal bone loss will be accepted
- Presence of \>1 mm of keratinized peri-implant mucosa.
- Absence of systemic diseases that could influence the outcome of the therapy (i.e. controlled diabetes, with HbA1c\<7, patients will be included).
- Non-smoker or light smoking status in smokers (\<10 cigarettes/day)
Exclusion
- Untreated periodontal conditions.
- Pregnant or lactating women.
- Patients who received systemic antibiotics in the last 3 months.
- Patients who received treatment of PM in the past 3 months.
- Patients receiving corticoids or medications known to have effect on gingival growth (i.e., calcium channel antagonists, immunosuppressants or antiepileptic drugs)
Key Trial Info
Start Date :
September 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06535958
Start Date
September 16 2024
End Date
April 9 2025
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitat Internacional de Catalunya
Barcelona, Sant Cugat Del Vallès, Spain, 08195